Issued from Nanjing Xianou Instruments Manufacture Co.,Ltd.

http://www.xo-instrument.com/news

A conference that covers the entire spectrum of drug delivery technologies and uncovers the needs of pharmas in Asia and globally.

World Drug Delivery Congress Asia Pacific is UNIQUE, it

--  covers the ENTIRE spectrum of drug delivery technologies for both small molecule and biologic drugs
--  features the MOST innovative Pharmas from over 15 Asian countries and regions
--  brings together KEY drug delivery decision makers from multinational pharmas, speciality and generic pharmas, as well as technology leaders, academics and other stakeholders

Featuring 30+ top notch speakers from Asia's leading pharma companies, 2 workshops covering the hottest topics on Nanotechnology & Biologic Formulation and Drug Delivery 101. Limited seats, register now to avoid disappointment!

Register now at http://www.imapac.com/index.php?page=world-drug-delivery-congress-2011

In 2009, the drug delivery market was valued at US$101 billion and is forecast to increase about two-folds to an estimate of US$200 billion by 2016.

A recent research have revealed that the pharmaceutical industry is increasingly recognizing the importance of drug delivery innovations in order to help them address challenges such as the patent cliffs and heightened competition.

Against this backdrop, World Drug Delivery Congress 2011 will bring together multinational, specialty and generic pharmaceutical companies from Asia Pacific and globally to exchange ideas and debate on how to leverage on innovative drug delivery technologies to create more value in their product pipelines.

This is Asia Pacific region’s FIRST and HIGHEST LEVEL gathering that brings together more than 50 key decision makers in the pharmaceutical industry in a never been done before event. Discussions are set to range from the developments of innovative drug formulation and delivery strategies, to the ability to create new revenue streams and sustainable partnerships.

The Concept

In 2009, the drug delivery market was valued at US$101 billion and is forecast to increase about two-folds to an estimate of US$200 billion by 2016.

The pharmaceutical industry is paying increasing attention to drug delivery strategies and they have since started to reap sizable rewards. The success of Omnitrope Pen 5 with liquid cartridge by Sandoz is a perfect example of how drug delivery innovations can make a difference to pharmaceutical sales performance.

Patent cliff is forcing pharma giants to think out of the box, and many has turned to novel drug delivery technologies for life-cycle extension. Facing increasing competitions from the originators and peers, generic pharmas have also started to realize the magical power of drug delivery technologies to create product differentiation in the market.
With both multinational and generic players utilizing drug delivery technologies to gain a similar objective of remaining in business, it is not surprising that the drug delivery market have been experiencing high growths. This is driven mainly by the new value proposition of drug delivery, the cost effective manufacture of new delivery materials as well as advances in these technologies.

In order to move the industry forward, pharmaceutical companies, drug delivery firms and all relevant stakeholders should come together to explore new innovations and exploit existing synergies.

World Drug Delivery Congress is designed for this purpose of allowing top decision makers from multinational and generic pharmaceutical companies to meet drug delivery firms and biotechs and unravel the full potential that drug delivery has on their product pipelines.

Discussions include determining new revenue streams, identifying new and innovative technologies suitable for your product lines and forming strategic partnerships. Together, the drug industry can develop safer, better and more cost effective drugs for all patients worldwide.

The Speakers

Jack Aurora, CSO, Hisunpharma, China
Dr Yuen Kah Hay, Director R&D, Hovid, Malaysia
Deepak Murpani, VP R&D (product development), Genepharm, Greece
VipanDhall, Site Head Pharmaceutical development services, Piramal Healthcare, India
Peter Hoffmann, Vice president new technology development, Genzyme Corporation, USA
Ursula Redeker, Head Technical Dev Biologics, F. Hoffman La-Roche, Switzerland
ChandirRamani, Head Product Development, Pharmaniaga, Malaysia
MotoichiKurisawa Team Leader and Principal Research Scientist, Institute of Bioengineering and Nanotechnology, Singapore
Keith Horspool, Vice president Pharmaceutics, BoehringerIngelheim, Germany
David Monteith, Head pharmaceutical emerging markets, Merck &Co., USA
Hsu Chang Shan, President, Innopharmax, Taiwan
Vincent Lee, Professor pharmacy, Chinese University of Hong Kong, Hong Kong
Julie Liu, Head Development and Regulatory Oncology injectables, Sandoz, Austria
Kennie Dee, Vice-President Research and development, United Laboratories, Inc., Philippines
Henry Sun, VP Research, Tianjin Tasly Group, China
Ravi Kiron, Managing Director, Adjuant global advisors LLC, USA
MangeshDeshpande, Manager Formulations R&D, Dr Reddy Laboratories, India
NazaneenPourkavoos. Principal Scientist, protein formulation and drug delivery, Novo Nordisk A/S, Denmark
Dr. Yunlong Tseng, Director of R&D, Taiwan Liposome Company, Taiwan
Dr Li You Xin, Vice president, Head of Group R&D, Luye pharmaceutical, China
VinodArora, VP pharma R&D, Ranbaxy, India
LeeChee Wee, Founder and scientific advisor, Lynk Biotech, Singapore

World Drug Delivery 2011 will give you the unique opportunity to position your business in front of 200 Asia’s top CSOs and formulations heads that are interested in novel delivery systems.

In order to get the right audience for you, our internal resources are fully geared towards attracting the largest and most active companies in the drug delivery industry in Asia and the rest of the world. We also work with a wide range of media partners and industry bodies to guarantee this audience.

Why should you sponsor?

World Drug Delivery 2011 will provide commercial organisations with the opportunity to:

·  Educate the market about what you offer.
·  Position yourselves as leaders in your field alongside key industry figures.
·  Raise brand awareness
·  Enjoy the option of privately arranged meetings and consultations with selected potential clients.
·  Hold face to face meetings with your target profile

Who should sponsor?

World-class solution providers who need to position their products and services in front of decision makers from major big pharmas, generic pharmas and speciality pharmas such as:

·  Drug Delivery Technology
·  Formulation Development Services
·  Excipients
·  Contract Manufacturing Organisations
·  Contract Research Organisations
·  Equipment Providers
·  Distribution and Logistics
·  Cold Chain Storage
·  Packaging
·  Automation
·  Biotechs

No other Drug Delivery event can get you one-to-one access to senior decision-makers from both Asia and global leaders. Make sure you get access to Asia’s hottest  lifescience industry and aren’t missing out this opportunity. See a real ROI by being part of the drug delivery industry’s most comprehensive marketing campaign.

This is an exceptional opportunity to position your brand and business before the World’s top speciality and generic pharma executives.

To find out more about becoming one of our partners for this event, please do not hesitate to contact Priscilla Liu @+65 6493 2096 or email: Priscilla.liu@imapac.com .

Contact Us

IMAPAC Pte Ltd
8 Eu Tong Sen Street
#17-86 The Central
Singapore 059818

Tel: +65 6493 2093
Fax:+65 6222 5256
info@imapac.com

For more information on speakin, sponsorship and exhibition opportunities, kindly contact:

Jasmine Wong
Tel: +65 6493 1598
Fax: +65 6222 5256
Email: jasmine.wong@imapac.com

For more information on media partnerships and logistics of the event, kindly contact:
Hu Shu
Tel: +65 6493 2093
Fax: +65 6222 5256
Email: shu.hu@imapac.com